checkAd
    Startseite > Aktien > Turnstone Biologics > Nachrichten
    Turnstone Biologics Aktie
    2,6100
     
    USD
    -0,76 %
    -0,0200 USD
    Letzter Kurs 01.06.24 Nasdaq
    2,5800
     
    USD
    2.300 STK
    Geldkurs 31.05.24
    2,6000
     
    USD
    1.600 STK
    Briefkurs 31.05.24
    ISIN: US90042W1009 · WKN: A3EMMR · SYM: TSBX · USA

    Neueste Nachrichten

    Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
    13.05.24 · globenewswire · Turnstone Biologics
    Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference
    08.05.24 · globenewswire · Turnstone Biologics
    Turnstone Biologics Appoints William Waddill to its Board of Directors
    16.04.24 · globenewswire · Turnstone Biologics
    Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights
    21.03.24 · globenewswire · Turnstone Biologics
    Turnstone Biologics to Participate in Upcoming Investor Conferences
    21.02.24 · globenewswire · Turnstone Biologics
    Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.
    20.02.24 · globenewswire · Turnstone Biologics
    Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference
    27.11.23 · globenewswire · Turnstone Biologics
    Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
    10.11.23 · globenewswire · Turnstone Biologics
    Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting
    03.11.23 · globenewswire · Turnstone Biologics
    Turnstone Biologics Expands Scientific Advisory Board with Appointment of Dr. Jeffrey S. Weber
    30.10.23 · globenewswire · Turnstone Biologics
    Turnstone Biologics to Present Preclinical Data for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy at Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
    28.09.23 · globenewswire · Turnstone Biologics